Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Baxter International
(NY:
BAX
)
38.96
+0.14 (+0.36%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Baxter International
< Previous
1
2
3
4
5
6
7
Next >
Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System
April 01, 2024
FDA clears Baxter's Novum IQ LVP & SYR infusion pumps with Dose IQ Safety Software, streamlining training & reducing cognitive burden. Explore enhanced safety features & EMR interoperability.
Via
Benzinga
Exposures
Product Safety
Becton, Dickinson And Co. Dividend Stock Analysis
March 23, 2024
Becton, Dickinson, and Co. provides a wide range of medical devices and diagnostic products used in hospitals, doctors' offices, research labs, and other settings.
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
March 20, 2024
Via
Benzinga
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
March 05, 2024
Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks
Via
Benzinga
Stock Market Commentary: “Volumes Are The Name Of The Game…”
February 23, 2024
Short, intermediate, and long term outlook on the market. Plus, a deep dive into our thesis on Cooper Standard
Via
Talk Markets
Earnings Scheduled For February 8, 2024
February 08, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Via
Benzinga
Earnings Outlook For Baxter Intl
November 01, 2023
Via
Benzinga
7 Analysts Have This to Say About Baxter Intl
August 21, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Baxter Intl
July 28, 2023
Via
Benzinga
Barclays Maintains Overweight Rating for Baxter Intl: Here's What You Need To Know
February 12, 2024
Via
Benzinga
Baxter Says 2023 Performance Reflects Strategic Initiatives With New Operating Model Without BioPharma Solutions Unit
February 08, 2024
Baxter's Q4 2023 results: $3.89 billion revenue, surpassing consensus, 4% Y/Y growth. Strong sales in Medical Products, Therapies, Kidney Care, and Pharmaceuticals segments.
Via
Benzinga
Top Picks 2024: Baxter International
January 06, 2024
Baxter International (BAX) has four divisions: Medical Products & Therapies, Healthcare Systems & Technologies, Pharmaceuticals, and Kidney Care. The stock aggressively sold off ~65%
Via
Talk Markets
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
December 18, 2023
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records.
Via
Talk Markets
3 Of Our Favorite Dividend Stocks For The New Year
December 17, 2023
The S&P 500 Index appears to be wrapping up a strong year, registering a year-to-date total return of 22.2%. The good news is that there are still undervalued stocks with strong dividends to choose...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts
December 12, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Morgan Stanley Maintains Equal-Weight Rating for Baxter Intl: Here's What You Need To Know
December 04, 2023
Via
Benzinga
Most Active Equity Options For Midday - Monday, Nov. 13
November 13, 2023
Here are the most active equity options for midday.
Via
Talk Markets
Why Is Dialysis Device And Kidney Care Provider Baxter Stock Trading Higher Today?
November 02, 2023
Baxter International Inc (NYSE: BAX) posted Q3 revenue of $3.71 billion, which beat the consensus of $3.69 billion, up 3% Y/Y on a reported basis and
Via
Benzinga
Most Active Equity Options For Midday - Wednesday, Oct. 12
October 12, 2023
Here are the most active equity options for midday.
Via
Talk Markets
Why Investors Punished Baxter International Stock Today
October 11, 2023
The latest data from the lab could spell trouble for the company.
Via
The Motley Fool
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 11, 2023
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in...
Via
Benzinga
What's Going On With Kidney Dialysis Provider Stocks Today?
October 11, 2023
DaVita Inc (NYSE: DVA), Fresenius Medical Care AG (NYSE: FMS), and Baxter International Inc (NYSE: BAX) shares fel
Via
Benzinga
Silk Road Medical, E2open And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
October 11, 2023
U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 10, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2023
Via
Benzinga
“At The Starting Gate” Stock Market (And Sentiment Results)
August 24, 2023
The NAAIM (National Association of Active Investment Managers Index) (Video Explanation) dropped to 59.87% this week from 65.49% equity exposure last week.
Via
Talk Markets
S&P 500: Entertainment Giants, AI Play Lead Monday's 5 Best; Medtech Firms Sicken
July 31, 2023
DexCom and several medical products firms struggled.
Via
Investor's Business Daily
Software Update Leads To False Alarms In Baxter's Spectrum Infusion Pumps, Urgent Correction Underway
July 31, 2023
Baxter International Inc (NYSE: BAX) has
Via
Benzinga
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
July 31, 2023
Keybanc cut the price target for Baxter International Inc. (NYSE: BAX) from $53 to $51. Keybanc analyst Matthew Mishan maintained an Overweight rating. Baxter International shares rose 1.2% to $47.58...
Via
Benzinga
Baxter Posts Mixed Q2 Earnings, Stock Falls On Lagging FY23 Outlook
July 27, 2023
Baxter International Inc (NYSE: BAX) posted Q2 revenue of $3.71 billion, which missed the consensus of $3.79 billion, up 3% Y/Y on a reported basis and up
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.